Home/Pipeline/NCEs for Pain Management

NCEs for Pain Management

Pain

Preclinical/DiscoveryActive

Key Facts

Indication

Pain

Phase

Preclinical/Discovery

Status

Active

Company

Ipca Laboratories

About Ipca Laboratories

Ipca Laboratories is a mission-driven, fully integrated global pharmaceutical company dedicated to advancing healthcare through quality, affordable medicines. Its strategic achievements include establishing world-leading API manufacturing capabilities, securing approvals from stringent global regulators, and building a robust international footprint. The company's core strategy hinges on vertical integration for cost and supply chain control, therapeutic area dominance, and a growing R&D focus on novel drugs and biologics to drive future growth.

View full company profile

Therapeutic Areas

Anti-malarials Analgesics/Pain Anti-inflammatory Cardiovascular Anti-diabetics Anti-infectives Hair Care

Other Pain Drugs

Drug	Company	Phase	Status
Desmetramadol	Syntrix Pharmaceuticals	Clinical Development	Active
Diclofenac Potassium Powder for Oral Solution	Patrin Pharma	Approved	Active
CG001419	Cullgen	Phase 1	Active
Proprietary Pain Program(s)	Oblique Therapeutics	Pre-clinical	Active
Undisclosed	Camurus	Clinical	Active
Pain Management APIs	Noramco	Commercial	Active
Dipendium (Diclofenac Potassium)	NovaMedica	Approved	Active
Na ion channel TicTACs	Solu Therapeutics	Preclinical	Active
Infusional Pain Management (e.g., Paracetamol)	Galenica Senese	Commercial	Active
XEN1701	Xenon Pharmaceuticals	Phase 1	Clinical trial initiated